TransMedics - FY2026 Q3 Earnings
$TMDX $81.25 [+18.1% AH]
✅ Revenue: $203.0M (Est: $181.8M) [+41% YoY]
✅ EPS: $0.51 (Est: $0.36), adjusted, GAAP $0.46
Additional Metrics:
Gross Margin: 58.5%
Adjusted Operating Income: $28.9M [+22% YoY]
Adjusted Operating Margin: 14.2%
Adjusted Net Income: $18.9M [-23% YoY]
Cash: $493.0M
Segment Revenue:
Product: $113.4M [+29% YoY]
Service: $89.6M [+60% YoY]
FY2026 Guidance:
Revenue: $764-774M incl. $14M PAD Aviation
Revenue ex-PAD: $750-760M (Prior: $737-757M)
顯示更多